| Financial Year |
March 31 2023 |
| Monetary Funds |
596,795,965.89 |
| Held-for-trading Financial Assets |
1,550,066.24 |
| Notes Receivable |
85,729,672.18 |
| Accounts Receivable |
878,620,843.79 |
| Advances to Suppliers |
123,290,852.45 |
| Other Receivables |
27,903,952.30 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
546,909,643.98 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
22,233,012.18 |
| Total Current Assets |
3,241,831,258.79 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
313,316,195.01 |
| Investment Properties |
17,756,004.74 |
| Fixed Assetes |
152,966,412.41 |
| Under-construction Projects |
8,838,938.50 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
86,803,626.90 |
| R&D expenses |
-- |
| Goodwill |
165,536,951.46 |
| Long-Term Deferred and Prepaid Expenses |
2,143,243.49 |
| Deferred Income Tax Assets |
128,326,078.67 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
903,495,807.19 |
| Total Assets |
4,145,327,065.99 |
| Short-Term Loans |
611,050,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
780,405,452.61 |
| Accounts Payable |
1,139,473,169.86 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
19,120,622.38 |
| Taxes Payable |
28,087,844.59 |
| Interest Payable |
1,404,075.57 |
| Dividend Payable |
-- |
| Other payables |
17,805,304.09 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
7,338,141.91 |
| Other Current Liabilities |
76,854,985.00 |
| Sub-Total of Current Liabilities |
3,323,220,443.57 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
223,938.75 |
| Special Payable |
-- |
| Estimatied Liabilities |
18,884,986.52 |
| Deferred Income Tax Liabilities |
4,097,930.19 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
38,866,597.62 |
| Total Liabilities |
3,362,087,041.19 |
| Paid-In Capital(Or Share Stock) |
490,298,992.00 |
| Capital Surplus |
282,484,263.23 |
| Surplus Reserve |
55,324,857.82 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-102,031,352.71 |
| Minority Stockholder's Interest |
54,485,764.45 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
728,754,260.35 |
| Owner's Equity（Stockholder's Equity） |
783,240,024.80 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,145,327,065.99 |
